Which hereditary sugar intolerance disorders make mebeverine hydrochloride 200 mg modified-release capsules in the Aspire Pharma Ltd product unsuitable?

Mebeverine hydrochloride 200 mg modified-release capsules in the Aspire Pharma Ltd product should not be taken by patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltese insufficiency.